Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Staffan Lindblad

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Plos One|February 25, 2010
Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritisMauro D'Amato, Marco Zucchelli, Maria Seddighzadeh, et al.
Plos One|March 30, 2011
Effects of GSTM1 in rheumatoid arthritis; results from the Swedish EIRA studyEmeli Lundström, Toinette Hartshorne, Kelly Li, et al.
Arthritis Research & Therapy|June 4, 2009
Evaluation of arthroscopy and macroscopic scoringErik af Klint, Anca I Catrina, Peter Matt, et al.
Plos One|September 10, 2014
Accelerating translational research by clinically driven development of an informatics platform--a case studyImad Abugessaisa, Saedis Saevarsdottir, Giorgos Tsipras, et al.
European Journal of Human Genetics : EJHG|March 31, 2011
Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritisMarina Korotkova, Nina A Daha, Maria Seddighzadeh, et al.
BMJ (Clinical Research Ed.)|July 3, 2016
Patient focused registries can improve health, care, and scienceEugene C Nelson, Mary Dixon-Woods, Paul B Batalden, et al.
Arthritis and Rheumatism|June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenJohan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases|January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsJohan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism|October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Rheumatology (Oxford, England)|November 19, 2010
Ten years with biologics: to whom do data on effectiveness and safety apply?Julia F Simard, Elizabeth V Arkema, Anders Sundström, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos One|February 25, 2010
Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritisMauro D'Amato, Marco Zucchelli, Maria Seddighzadeh, et al.
Plos One|March 30, 2011
Effects of GSTM1 in rheumatoid arthritis; results from the Swedish EIRA studyEmeli Lundström, Toinette Hartshorne, Kelly Li, et al.
Arthritis Research & Therapy|June 4, 2009
Evaluation of arthroscopy and macroscopic scoringErik af Klint, Anca I Catrina, Peter Matt, et al.
Plos One|September 10, 2014
Accelerating translational research by clinically driven development of an informatics platform--a case studyImad Abugessaisa, Saedis Saevarsdottir, Giorgos Tsipras, et al.
European Journal of Human Genetics : EJHG|March 31, 2011
Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritisMarina Korotkova, Nina A Daha, Maria Seddighzadeh, et al.
BMJ (Clinical Research Ed.)|July 3, 2016
Patient focused registries can improve health, care, and scienceEugene C Nelson, Mary Dixon-Woods, Paul B Batalden, et al.
Arthritis and Rheumatism|June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenJohan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases|January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsJohan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism|October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Rheumatology (Oxford, England)|November 19, 2010
Ten years with biologics: to whom do data on effectiveness and safety apply?Julia F Simard, Elizabeth V Arkema, Anders Sundström, et al.
Pageof 3